Primecap Management’s Mural Oncology MURA Stock Holding History

Primecap Management’s Portfolio MURA Stock Details MURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-92,800	Closed	-$192K	–	331
2025 Q3	$192K	Hold	92,800	–	–	﹤0.01%	326
2025 Q2	$229K	Sell	92,800 -45,003	-33%	-$106K	﹤0.01%	326
2025 Q1	$174K	Sell	137,803 -1,442	-1%	-$5.26K	﹤0.01%	334
2024 Q4	$448K	Sell	139,245 -800	-0.6%	-$2.82K	﹤0.01%	324
2024 Q3	$438K	Sell	140,045 -95,506	-41%	-$311K	﹤0.01%	328
2024 Q2	$740K	Sell	235,551 -11,908	-5%	-$43.9K	﹤0.01%	324
2024 Q1	$1.21M	Sell	247,459 -8,796	-3%	-$42.7K	﹤0.01%	320
2023 Q4	$1.52M	Buy	+256,255	New	+$1.03M	﹤0.01%	319

Primecap Management's MURA Position: Q4 2025 in Review

Primecap Management sold out of Mural Oncology (MURA) in Q4 2025, closing a stake of 92,800 shares — an estimated $192K sold.

Primecap Management first reported a position in MURA in Q4 2023 and held it in 8 quarters. The position peaked at $1.52M in Q4 2023. 0 funds tracked by Wall St. Rank hold MURA as of Q4 2025.

Primecap Management reported no remaining Mural Oncology position as of Q4 2025 after selling out during the quarter.
Primecap Management sold 92,800 Mural Oncology shares in Q4 2025, an estimated $192K.
Primecap Management first reported a position in Mural Oncology in Q4 2023 and held it in 8 quarters.
Primecap Management's Mural Oncology position peaked at $1.52M in Q4 2023.
0 funds tracked by Wall St. Rank held Mural Oncology as of Q4 2025.

Based on Primecap Management's 13F filing for Q4 2025, filed 11 Feb 2026.